Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President of Investor Relations and Corporate Communications Frederick Vogt - Interim President and Chief Executive Officer Jean-Marc Bellemin - Chief Financial Officer Igor Bilinsky - Chief Operating Officer James Ziegler - Executive Vice President, Commercial Friedrich Finckenstein - Chief Medical Officer Madan Jagasia - Executive Vice President, Medica ...